Revenue-driven in TB control--three cases in China
- PMID: 15686061
- DOI: 10.1002/hpm.778
Revenue-driven in TB control--three cases in China
Abstract
One quarter of all TB cases occur in China, which, during the past 20 years has moved from a planned economy to a socialist market economy. In the health sector, an important proportion of the financing originates from user payment. TB control is not an exception and different programmatic models are in place. This study examines, using a case study approach, three different TB programmes, one supposed to provide free service, one subsidized service and one with full cost recovery. The aim was to better understand the driving forces for programme performance in terms of case detection, case management and patient payments. The study found for all models that control and case management approaches were, to some extent, adapted to generate maximum income to the providers. The drive for income led to fewer cases detected, administration of unnecessary procedures and drugs, and a higher than necessary cost to the patients. The latter possibly leading to exclusion of poor people from the services. If user charges are to stay, TB control programmes need to be designed to take advantage of the financial incentives to improve performance. The referral system needs to be restructured, not to provide disincentives for good practices.
Similar articles
-
Provision and financial burden of TB services in a financially decentralized system: a case study from Shandong, China.Int J Health Plann Manage. 2004 Oct-Dec;19 Suppl 1:S45-62. doi: 10.1002/hpm.774. Int J Health Plann Manage. 2004. PMID: 15686060
-
The management for tuberculosis control in Greater London in comparison with that in Osaka City: lessons for improvement of TB control management in Osaka City urban setting.Health Policy. 2005 Jul;73(1):104-23. doi: 10.1016/j.healthpol.2004.11.006. Epub 2004 Dec 13. Health Policy. 2005. PMID: 15911061
-
How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives.Trop Med Int Health. 2007 Dec;12(12):1464-71. doi: 10.1111/j.1365-3156.2007.01953.x. Trop Med Int Health. 2007. PMID: 18076553
-
Effective tuberculosis control and health sector reforms in Kenya: challenges of an increasing tuberculosis burden and opportunities through reform.Int J Tuberc Lung Dis. 2000 Jul;4(7):627-32. Int J Tuberc Lung Dis. 2000. PMID: 10907765 Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
Cited by
-
Persistent problems of access to appropriate, affordable TB services in rural China: experiences of different socio-economic groups.BMC Public Health. 2007 Feb 8;7:19. doi: 10.1186/1471-2458-7-19. BMC Public Health. 2007. PMID: 17288593 Free PMC article.
-
Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies.BMC Public Health. 2008 Oct 21;8:365. doi: 10.1186/1471-2458-8-365. BMC Public Health. 2008. PMID: 18939987 Free PMC article.
-
The impact of the new cooperative medical scheme on financial burden of tuberculosis patients: evidence from six counties in China.Infect Dis Poverty. 2016 Jan 28;5:8. doi: 10.1186/s40249-015-0094-5. Infect Dis Poverty. 2016. PMID: 26818723 Free PMC article.
-
Tuberculosis Hospitalization Fees and Bed Utilization in China from 1999 to 2009: The Results of a National Survey of Tuberculosis Specialized Hospitals.PLoS One. 2015 Oct 12;10(10):e0139901. doi: 10.1371/journal.pone.0139901. eCollection 2015. PLoS One. 2015. PMID: 26457980 Free PMC article.
-
Factors associated with catastrophic total costs due to tuberculosis under a designated hospital service model: a cross-sectional study in China.BMC Public Health. 2020 Jun 26;20(1):1009. doi: 10.1186/s12889-020-09136-z. BMC Public Health. 2020. PMID: 32586305 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous